Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-06

Clinical Trial Update: Heterosexual HIV Transmission Study (HATS)

View source ↗

Summary

The Heterosexual HIV Transmission Study (HATS), sponsored by NIAID, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Healthy | Status: COMPLETED